Will Roche Holding (RHHBY) Stock Be Helped By Seragon Pharmaceuticals Purchase?

NEW YORK (TheStreet) -- Roche Holding Ltd.  (RHHBY) will pay up to $1.725 billion to buy Seragon Pharmaceuticals, a privately-held, San Diego-based biotech company that researches breast cancer treatments, Reuters reports.

The company was spun out from Aragon Pharmaceuticals in 2013 when that company was bought by Johnson & Johnson  (JNJ), Reuters noted.

Roche Holding shares closed slightly lower at $37.29 yesterday.

Must Read: Warren Buffett's 25 Favorite Growth Stocks

 
RHHBY Chart

RHHBY data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Dow Set to Snap 8-Day Losing Streak as Stocks Recover, But Trade War Lingers

Dow Set to Snap 8-Day Losing Streak as Stocks Recover, But Trade War Lingers

OPEC, Bank Stress Tests, Disney and Tesla - 5 Things You Must Know

OPEC, Bank Stress Tests, Disney and Tesla - 5 Things You Must Know

Big Banks Pass the Stress Tests and 4 Other Stories to Watch Friday Morning

Big Banks Pass the Stress Tests and 4 Other Stories to Watch Friday Morning

OPEC Debating 1 Million Barrel Oil Market Boost as Iran Signals Support

OPEC Debating 1 Million Barrel Oil Market Boost as Iran Signals Support